Pharmaids Pharmaceuticals

Small Cap 1.7k Result

₹39.00

-0.2 (-0.51%)

As on 30 September, 2023 | 06:12 BSE: 524572 NSE: PHARMAIDISIN: INE117D01018

Pharmaids Pharmaceuticals Performance

Day Range

Low
High

39.00

52 Week Range

Low
High

39.00

Open Price
Previous Close
Volume

Start SIP in Pharmaids Pharmaceuticals

Start SIP

Pharmaids Pharmaceuticals Share Price

Over 1 Month -2.5%
Over 3 Month -7.3%
Over 6 Month 78.82%
Over 1 Year 189.1%

Pharmaids Pharmaceuticals Key Statistics

Pharmaids Pharmaceuticals Investment Rating

Master Rating:
Pharmaids Pharms. has an operating revenue of Rs. 0.30 Cr. on a trailing 12-month basis. Pre-tax margin of 0% needs improvement, ROE of -33% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 62% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 3 which is a POOR score indicating inconsistency in earnings, a RS Rating of 83 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 111 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Overall, the stock has some relative strength and buyer demand but we want to see further fundamental performance to qualify as a growth stock.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Pharmaids Pharmaceuticals Financials

Standalone Consolidated

Quarterly P&L
Annual P&L
Balance Sheet
Cash Flow
Ratios
Quarterly P&L
Annual P&L
Balance Sheet
Cash Flow
Ratios

Indicator	Jun 2023	Mar 2023	Dec 2022	Sep 2022
Oper Rev Qtr Cr	0	0	0	0
Operating Expenses Qtr Cr	2	9	1	1
Operating Profit Qtr Cr	-2	-9	-1	-1
Depreciation Qtr Cr	0	0	0	0
Interest Qtr Cr	0	0	0	0
Tax Qtr Cr	0	-2	0	0
Net Profit Qtr Cr	-1	-6	-1	-1

Indicator	Mar 2023	Mar 2022
Total Revenue Annual Cr	0	4
Operating Expenses Annual Cr	10	4
Operating Profit Annual in Cr	-10	0
Depreciation Cr	0	0
Interest Annual Cr	0	0
Tax Annual Cr	-2	0
Net Profit Annual Cr	-8	0

Indicator	Mar 2023	Mar 2022
Cash from Operating Activity Annual Cr	-4	0
Cash from Investing Activity Annual Cr	-5	0
Cash from Financing Annual Activity Cr	21
Net Cash Flow Annual Cr	12	0

Indicator	Mar 2023	Mar 2022
Total ShareHolders Funds Annual Cr	22	9
Fixed Assets Annual Cr	2	0
Total Non Current Assets Annual Cr	7	8
Total Current Assets Annual Cr	17	3
Total Assets Annual Cr	25	11

Indicator	Mar 2023	Mar 2022
Book Value Per Share Annual Rs	10	8
ROE Annual %	-34	2
ROCE Annual %	-44	2
Total Debt to Total Equity Annual	-	-
EBDIT Annual Margin %	0	4

Indicator	Jun 2023	Mar 2023	Dec 2022
Oper Rev Qtr Cr	0	0	0
Operating Expenses Qtr Cr	2	9	1
Operating Profit Qtr Cr	-2	-9	-1
Depreciation Qtr Cr	0	0	0
Interest Qtr Cr	0	0	0
Tax Qtr Cr	0	-2	0
Net Profit Qtr Cr	-1	-6	-1

Indicator	Mar 2023	Mar 2022
Total Revenue Annual Cr	0	4
Operating Expenses Annual Cr	10	4
Operating Profit Annual in Cr	-10	0
Depreciation Cr	0	0
Interest Annual Cr	0	0
Tax Annual Cr	-2	0
Net Profit Annual Cr	-8	0

Indicator	Mar 2023	Mar 2022
Cash from Operating Activity Annual Cr	-4	0
Cash from Investing Activity Annual Cr	-5	0
Cash from Financing Annual Activity Cr	21
Net Cash Flow Annual Cr	12	0

Indicator	Mar 2023	Mar 2022
Total ShareHolders Funds Annual Cr	22	9
Fixed Assets Annual Cr	2	0
Total Non Current Assets Annual Cr	7	8
Total Current Assets Annual Cr	18	3
Total Assets Annual Cr	25	11

Indicator	Mar 2023	Mar 2022
Book Value Per Share Annual Rs	10	8
ROE Annual %	-34	2
ROCE Annual %	-44	2
Total Debt to Total Equity Annual	-	-
EBDIT Annual Margin %	0	4

Pharmaids Pharmaceuticals Technicals

EMA & SMA

Current Price

₹39.00

-0.2 (-0.51%)

Bullish Moving Average
___
14

Bearish Moving Average
___
2

EMA SMA

20 Day
₹38.43

50 Day
₹37.3

100 Day
₹33.62

200 Day
₹27.71

20 Day
₹38.18

50 Day
₹38.41

100 Day
₹34.41

200 Day
₹24.24

Pharmaids Pharmaceuticals Resistance and Support

PIVOT

₹38.88

Resistance
First Resistance	₹39.33
Second Resistance	₹39.66
Third Resistance	₹40.11

RSI	53.44
MFI	54.68
MACD Single Line	0.23
MACD	0.45

Support
First Resistance	₹38.55
Second Resistance	₹38.1
Third Resistance	₹37.77

Pharmaids Pharmaceuticals Delivery and Volume

Period	NSE + BSE Volume Avg	NSE + BSE Delivery Volume Avg	NSE + BSE Delivery Volume %
Day	2,675	267,500	100
Week	13,043	1,304,300	100
1 Month	9,808	980,786	100
6 Month	8,261	826,132	100

Pharmaids Pharmaceuticals Result Highlights

Pharmaids Pharmaceuticals Synopsis

BSE-Medical-Diversified

Pharmaids Pharma belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 0.00 Cr. and Equity Capital is Rs. 21.44 Cr. for the Year ended 31/03/2023. Pharmaids Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 01/03/1989 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L52520KA1989PLC173979 and registration number is 173979.

Market Cap	84
Sales
Shares in Float	1.93
No of funds
Yield

Book Value	3.73
U/D Vol ratio	0.7
LTDebt / Equity
Alpha	0.79
Beta	0.63

Pharmaids Pharmaceuticals

Owner Name	Jun-23	Mar-23	Jan-23	Dec-22
Promoters	9.94%	9.95%	16.45%	16.54%
Individual Investors	81.28%	81.71%	69.87%	69.78%
Others	8.78%	8.34%	13.68%	13.68%

Pharmaids Pharmaceuticals Management

Name	Designation
Mr. Venu Madhava Kaparthy	Executive Director
Ms. Mini Manikantan	Executive Director
Mr. Venkata Rao Sadhanala	Non Exe.Non Ind.Director
Mr. Mopperthy Sudheer	Independent Director
Mr. Methuku Nagesh	Independent Director
Mr. P N Vijay	Independent Director

Pharmaids Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)

1,758(-3.5%)

1,590(-12.7%)

Other Analyst Rating

Pharmaids Pharmaceuticals Corporate Action

Board

Date	Purpose	Remarks
2023-08-04	Quarterly Results
2023-05-29	Audited Results
2023-02-13	Quarterly Results
2023-01-17	Others
2022-12-06	Others	Rs.0.00 to consider Preferential issue of 84,00,000 equity shares of Rs. 10/- each in accordance with applicable provisions and subject to necessary approvals..